Qatar Team Pioneers 3-Minute AI Eye Scan to Detect Nerve Disease 5 Years Early
Updated
Updated · TheCurrrent.pk · May 19
Qatar Team Pioneers 3-Minute AI Eye Scan to Detect Nerve Disease 5 Years Early
7 articles · Updated · TheCurrrent.pk · May 19
Weill Cornell Medicine-Qatar said the AI-powered corneal confocal microscopy scan can flag diabetic neuropathy at least 5 years before symptoms and detect dementia, Parkinson’s and multiple sclerosis up to 3 years early.
The 2-3 minute test images sub-basal corneal nerve fibers, then uses deep-learning software to measure nerve density, length and branching within seconds to distinguish healthy tissue from early pathology.
Professor Rayaz Malik’s team says the non-invasive method can reveal peripheral nerve damage and central nervous system decline without skin biopsies or costly conventional imaging, potentially enabling earlier treatment.
Built on standard ophthalmic imaging equipment after 25 years of research, the tool is now being assessed in global clinical trials for tracking treatment response and nerve regeneration.
If your eyes are a window to brain health, what other diseases will AI soon detect through a simple eye scan?
This AI eye scan predicts dementia years early. Without a cure, what is the true cost of knowing your future?
An AI can now predict brain disease in minutes. Why might doctors hesitate to adopt this revolutionary technology?
Revolutionizing Early Disease Detection: AI Eye Scan Spots Dementia, Parkinson’s, and Diabetic Neuropathy in Minutes
Overview
A groundbreaking, non-invasive AI-powered eye scan, pioneered by Professor Rayaz Malik, uses corneal confocal microscopy to rapidly detect early signs of serious diseases like dementia, Parkinson’s, and diabetic nerve damage. This scan takes only two to three minutes, making it a highly efficient diagnostic tool. Its ability to identify disease markers years before symptoms appear offers a crucial window for early intervention. The rapid and non-invasive nature of the technology means doctors can manage progressive conditions more effectively, potentially transforming early diagnosis and treatment for patients worldwide.